Is improved detection of adenocarcinoma in situ by screening a key to reducing the incidence of cervical adenocarcinoma?
Kari
K
Syrjänen
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology* / Q000517:prevention & control; D002278:Carcinoma in Situ / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015994:Incidence; D008403:Mass Screening / Q000592:standards* / Q000706:statistics & numerical data; D008487:Medical History Taking / Q000592:standards / Q000706:statistics & numerical data; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology* / Q000517:prevention & control; D014626:Vaginal Smears / Q000592:standards* / Q000706:statistics & numerical data